Shell plc (SHEL): what the price requires
The current priced-in claim for Shell plc (SHEL) is temporarily suppressed because the live engine record is unavailable. The dated report remains a snapshot, not a current market read.
Generated: 2026-07-19 · Exported: 2026-07-20 · Source: https://boothcheck.com/report/SHEL
Headline
| Field | Value |
|---|---|
| Ticker | SHEL |
| Company | Shell plc |
| Sector / Industry | Energy |
| Current price | $87.34/sh |
What The Price Requires (Inversion)
The assumption today's price embeds, recovered by inverting the valuation.
| Field | Value |
|---|---|
| Inversion basis | whole-company |
| Multiple paid | 11x operating income |
The price sits below what even a 5%/yr operating-profit decline would warrant; the inversion reports a bound, not a solved growth path.
Solve inputs: computed at a 7.2% cost of capital with 4% terminal growth over a 5-year stage.
Reconcile: at the x-ray's 9.3% required return this reads ~-2.7%/yr; the models below use their own rates.
How unusual the bet is: within-range (limited comparison data)
| Reference | Value |
|---|---|
| vs own history | -0.43σ |
| implied end-window share | 1% |
Valuation X-Ray
The price is supported by asset-based and earnings-power and relative-multiple and growth-DCF value. A value/asset-supported name, not a pure growth bet.
How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.
| Family | Median price/FV | Models | Reads |
|---|---|---|---|
| Asset | 1.12x | 3 | expensive |
| Earnings | 0.38x | 1 | justifies |
| Relative | 0.76x | 2 | justifies |
| Growth | 0.80x | 3 | justifies |
Families that justify the price: Asset, Earnings, Relative, Growth
The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 6.6%); the inversion above states its own rate.
Per-Model Detail (n=9)
| Model | Family | FV | Price/FV | Applicable | Methodology |
|---|---|---|---|---|---|
| DCF Perpetual Growth | Growth | $262.55 | 0.33x | yes | FCF base $70.7B, growth -9% (input: historical growth), terminal g 0.5%, WACC 6.6%, 5yr projection |
| DCF Exit Multiple | Growth | $0.00 | — | no | Negative/zero FCF or EBITDA — equity value floored at $0 |
| Relative Valuation | Relative | $115.55 | 0.76x | yes | P/S fallback (negative EPS): Sector P/S 1.2x × TTM revenue — excluded from consensus |
| Simple DDM | Growth | — | — | no | — |
| Two-Stage DDM | Growth | $108.60 | 0.80x | yes | Stage 1: 5% for 5yr, Stage 2: 3.5% perpetual |
| Simple Excess Return | Asset | $71.28 | 1.23x | yes | BV/sh $58.95, ROE (TTM) 11.2%, ke 9.3% |
| Two-Stage Excess Return | Asset | $78.08 | 1.12x | yes | 5yr excess ROE then converge to ke=9.3% |
| Discounted Future Market Cap | Growth | $41.61 | 2.10x | yes | Rev $286.4B, growth -9% (input: historical growth; tapered), Terminal P/S: 0.7x / 0.9x / 1.1x (bear / base = today's held flat / bull, cap 6x) |
| Peter Lynch Fair Value | Relative | $0.00 | — | no | Negative/zero EPS — earnings-based value floored at $0 |
| Margin Trajectory | Growth | — | — | no | — |
| Earnings Power Value | Earnings | — | — | no | — |
| Residual Income | Asset | $79.40 | 1.10x | yes | BV $58.95 + 5yr PV of (ROE (TTM) 11.2% − Kₑ 9.3%) × BV; BV grows 7.3%/yr |
| Graham Number | Asset | — | — | no | — |
| EV/EBITDA Relative | Relative | — | — | no | — |
| FCF Yield | Earnings | $229.34 | 0.38x | yes | FCF $70712.0M / Kₑ 9.3% — zero-growth perpetuity |
| SBC-Adj FCF Yield | Earnings | — | — | no | — |
| Ben Graham Formula | Earnings | — | — | no | — |
| ROIC-Justified P/B | Asset | — | — | no | — |
| P/Sales Sector | Relative | $115.55 | 0.76x | yes | Revenue $286.36B × sector P/S 1.2x |
| PEG Fair Value | Relative | — | — | no | — |
| Earnings Yield | Earnings | — | — | no | — |
| Funds From Operations Multiple | Relative | — | — | no | — |
| Clinical Phase NPV | Growth | — | — | no | — |
| Merton | Asset | — | — | no | — |
| V5 Mechanical | — | — | — | no | — |
Solvency
| Field | Value |
|---|---|
| Net debt | $45.4b |
| Net debt / NOPAT (after-tax) | 2.70x |
| Net debt / operating income (pre-tax) | 1.65x |
| Share count CAGR (buyback) | -6.5% |
| Burning cash | no |
Interest expense is not separately reported in the latest filings, so interest coverage cannot be computed.
Bullet Takeaways
- Shell is an integrated energy major the market is pricing as though its profits are set to slip rather than grow, which is an unusual starting point for a company this size.
- The central risk is the one every commodity cyclical carries: trailing operating income rests on a tape that has already turned, with revenue down about 8.7% over the last year, so that profit may sit nearer a peak than a durable run-rate.
- The next marker is Q2 2026 results on July 30, 2026, when the interim dividend and the size of the next buyback tranche will show how management reads its own cash generation.
Bull Case
Start with what the market is paying for. At $87.34 (July 19, 2026), Shell trades at about 11x its company-wide operating income, and that multiple is low enough that the price already builds in a decline. Read plainly, the market is treating today's operating profit as something that erodes from here, not something that holds or compounds. The fundamentals tell a less resigned story.
Line the price up against the ways of valuing the business and only one lens sits near it. The methods that read asset value plus profitability sit just under the price, at about 1.12x, so the asset base is close to a floor. The earnings-power methods, the peer multiple methods, and the growth DCF all reach above today's price. Meanwhile the company hands cash back at a pace few majors match: share count has fallen about 6.5% a year over the last four years, a steady shrinking of the denominator, and first-quarter distributions ran $5.3B, split $3.2B of buybacks and $2.1B of dividends.
The growth that is visible sits in gas. LNG Canada has started up with a second train still to come, and the pending purchase of Canadian producer ARC Resources is set to add about 370,000 barrels of oil equivalent a day and roughly $1.5B of annual free cash flow while feeding the LNG Canada Phase 2 expansion. None of this strains the balance sheet, where net debt runs about 1.65x trailing operating income against a comfortable stock of liquid assets. The bear will point at the cyclicality, and it is real. The answer is that the price already assumes the down-cycle the bear is worried about.
Bear Case
The question a Shell holder should sit with is not whether the company is cheap. It is whether management is giving back cash it ought to be keeping. Shell is retiring about 6.5% of its shares a year and paid out $5.3B in the first quarter alone, $3.2B of it in buybacks. It does this while carrying $45.4B of net debt. Buying back stock at that pace, on a balance sheet with that much debt, in a business whose cash flows rise and fall with a commodity price, is a wager that today's cash generation is the normal state of the world and not a high-water mark.
That is the harder half of the case. The trailing $27.6B of operating income sits on a tape that has already rolled over, with revenue off about 8.7% over the last year as oil and gas prices eased. The low multiple the price carries looks like cheapness, but it is conditional cheapness: it holds only if that $27.6B is closer to a mid-cycle run-rate than to a peak. Let operating profit mean-revert toward the lower end of the cycle and the distributions that were sized against strong cash get funded more and more from the balance sheet, while the buybacks that flatter per-share figures keep running as absolute profit falls.
Layered on top is a strategic straddle. Shell is directing roughly a third of a $22B to $25B capital budget toward low-carbon energy while spending billions a quarter buying its own shares. That split satisfies neither the investor who wants a pure hydrocarbon cash machine nor the one who wants a credible transition builder, and it leaves the reinvestment rate hostage to whichever camp is loudest in a given year. Underneath every line of the thesis sits one variable Shell does not control, the oil and gas price. The market's low multiple is not an oversight. It is the honest discount a buyer attaches to earnings borrowed from a cycle.
Valuation
At $87.34 (July 19, 2026), the price works out to about 11x Shell's company-wide operating income. That is a low number for a business of this scale. It is low enough that the price sits below what even a sustained mid-single-digit annual decline in operating profit would warrant, which is another way of saying the market is not asking the business to grow. It is asking whether it can avoid shrinking faster than that.
Line up the ways of valuing the company and the disagreement is the useful part. The methods that read asset value plus profitability sit just under the price, at about 1.12x, so the asset base acts as a floor. The earnings-power methods, the peer multiple methods, and the growth DCF all land above the price. That is the signature of a value-supported cyclical rather than a growth story: the floor under the price is what the company owns and earns today, and the room the other methods point to opens only if the cycle turns back up.
The balance sheet can carry the position. Net debt of $45.4B runs about 1.65x trailing operating income, a manageable load for a cash-generative major, so leverage is a fact to monitor rather than a threat. The caveat sits underneath all of it. Every one of these reads takes the trailing $27.6B of operating income as its base, and for an integrated major that figure is only as durable as the commodity cycle that produced it. The price is cheap on trailing profit. Whether it is cheap on sustainable profit is the question the buyer is actually answering.
Catalysts
The next scheduled event is the second-quarter 2026 report on July 30, 2026, which carries the interim dividend and, with it, the market's read on the pace of cash returns. The setup is a company already in full distribution mode. The first-quarter dividend was set at $0.3906 per share, and Shell began a $3.0B buyback on May 7, 2026 that it aimed to finish before the Q2 print.
The strategic story running underneath is a reshaping of gas and upstream. LNG Canada has reached start-up and a second train is still to come, and Shell is buying Canadian producer ARC Resources in a deal analysts frame as adding about 370,000 barrels of oil equivalent a day and roughly $1.5B of annual free cash flow, while supporting the LNG Canada Phase 2 expansion. For a company whose growth lever is increasingly liquefied gas rather than crude, both events matter more than a single quarter's price deck.
Sell-side sentiment holds at a buy consensus, though the targets scatter. Jefferies raised its target to $122.40 in May while keeping a buy rating, HSBC upgraded the stock to buy, and TD Cowen trimmed to $107 while staying constructive. Those marks sit above the current price, crediting the higher through-cycle cash flow and upstream growth that a trailing multiple does not yet reflect. The reinvestment side of the ledger is set by the 2026 budget of $22B to $25B in cash capital spending, about a third of it low-carbon.
Methodology Note
- Priced-in inversion: the valuation is inverted on the current price to recover the operating-income growth, duration, and steady-state margin the price embeds (ROE for financials, FFO growth for REITs).
- Valuation x-ray: the valuation models, grouped into four families (asset, earnings, relative, growth). Each model is expressed as a price/FV ratio (distance from price), not a point fair-value estimate. The spread across families is the disagreement.
- Solvency: net cash/debt, net-debt-to-NOPAT, interest coverage, and share-count CAGR from EDGAR financials (net debt / FFO and fixed-charge coverage for REITs; regulatory-capital framing for financials).
- Peer cohorts: per-segment comparables with deep-linkable SEC filing citations.
Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.
Sources
Shell to report Q2 2026 results and declare the Q2 interim dividend on July 30, 2026 · Shell Q1 2026 shareholder distributions of $5.3B, $3.2B buybacks and $2.1B dividends · analyst commentary on Shell's ARC Resources acquisition, 2026 · Shell Q1 2026 distributions, $3.2B buybacks and $2.1B dividends · Shell 2026 cash capex guidance of $22-25B, about one third to low-carbon · Shell to publish Q2 2026 results and declare the Q2 interim dividend on July 30, 2026 · Shell Q1 2026 interim dividend of $0.3906 per share; Shell commenced a $3.0B share buyback on May 7, 2026, to complete before Q2 2026 results · analyst commentary on Shell's ARC Resources acquisition and LNG Canada, 2026 · Jefferies raised SHEL target to $122.40, May 21, 2026; HSBC upgraded SHEL to Buy; TD Cowen trimmed SHEL target to $107 · Shell 2026 cash capex guidance of $22-25B, roughly one third low-carbon